Pub. L. 114-146, sec. 2 (as amended)
EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER PROGRAM TO ENCOURAGE TREATMENTS FOR ZIKA VIRUS DISEASE.
SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER PROGRAM TO ENCOURAGE TREATMENTS FOR ZIKA VIRUS DISEASE.
Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended—
(1) by redesignating subparagraph (R) as subparagraph (S);
(2) in subparagraph (Q), by striking “Filoviruses” and inserting “Filovirus Diseases”; and
(3) by inserting after subparagraph (Q) the following:
“(R) Zika Virus Disease.”
.